cDNA for bovine type 1 plasminogen activator inhibitor (PAI-1).
作者信息
Mimuro J, Sawdey M, Hattori M, Luskutoff D J
机构信息
Research Institute of Scripps Clinic, La Jolla, CA 92037.
出版信息
Nucleic Acids Res. 1989 Nov 11;17(21):8872. doi: 10.1093/nar/17.21.8872.
Abstract
摘要
相似文献
1
cDNA for bovine type 1 plasminogen activator inhibitor (PAI-1).牛1型纤溶酶原激活物抑制剂（PAI - 1）的互补DNA
Nucleic Acids Res. 1989 Nov 11;17(21):8872. doi: 10.1093/nar/17.21.8872.
2
Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.编码人β-迁移内皮细胞型纤溶酶原激活物抑制剂的cDNA的克隆与序列分析
Proc Natl Acad Sci U S A. 1986 Sep;83(18):6776-80. doi: 10.1073/pnas.83.18.6776.
3
Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor.编码人单核细胞源性纤溶酶原激活物抑制剂的cDNA的克隆与表达
Proc Natl Acad Sci U S A. 1988 Feb;85(4):985-9. doi: 10.1073/pnas.85.4.985.
4
cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.从内皮细胞中克隆人纤溶酶原激活物抑制剂的互补DNA
J Clin Invest. 1986 Dec;78(6):1673-80. doi: 10.1172/JCI112761.
5
Expression and characterization of recombinant porcine plasminogen activator inhibitor-1.重组猪纤溶酶原激活物抑制剂-1的表达与鉴定
Thromb Haemost. 1997 Feb;77(2):350-6.
6
Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1.影响组织型纤溶酶原激活剂与纤溶酶原激活剂抑制剂1相互作用的氨基酸残基。
Proc Natl Acad Sci U S A. 1990 May;87(9):3530-3. doi: 10.1073/pnas.87.9.3530.
7
Type 1 plasminogen activator inhibitor.
Prog Hemost Thromb. 1989;9:87-115.
8
Structure and function of human tissue-type plasminogen activator (t-PA).人组织型纤溶酶原激活剂（t-PA）的结构与功能
J Cell Biochem. 1986;32(3):169-78. doi: 10.1002/jcb.240320302.
9
The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator.人纤溶酶原激活物抑制剂1与组织纤溶酶原激活物之间的反应机制。
Biochem J. 1990 Jan 1;265(1):109-13. doi: 10.1042/bj2650109.
引用本文的文献
1
Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycle.乳腺癌与代谢综合征通过纤溶酶原激活物抑制剂-1循环相联系。
Bioessays. 2007 Oct;29(10):1029-38. doi: 10.1002/bies.20640.
2
Streptococcal modulation of cellular invasion via TGF-beta1 signaling.链球菌通过转化生长因子-β1信号传导对细胞侵袭的调节作用。
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2380-5. doi: 10.1073/pnas.0506668103. Epub 2006 Feb 7.
3
Species-specific differential cleavage and polyadenylation of plasminogen activator inhibitor type 1 hnRNA.1型纤溶酶原激活物抑制剂hnRNA的种属特异性差异切割和聚腺苷酸化
Nucleic Acids Res. 1993 Mar 25;21(6):1463-6. doi: 10.1093/nar/21.6.1463.
4
New nucleotide sequence data on the EMBL File Server.欧洲分子生物学实验室文件服务器上的新核苷酸序列数据。
Nucleic Acids Res. 1990 Jan 25;18(2):389-97. doi: 10.1093/nar/18.2.389.
5
Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.转化生长因子-β1 在体外调节碱性成纤维细胞生长因子诱导的内皮细胞蛋白水解和血管生成特性。
J Cell Biol. 1990 Aug;111(2):743-55. doi: 10.1083/jcb.111.2.743.
本文引用的文献
1
A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.GM-CSF信使核糖核酸3'非翻译区的一段保守AU序列介导选择性信使核糖核酸降解。
Cell. 1986 Aug 29;46(5):659-67. doi: 10.1016/0092-8674(86)90341-7.
2
Bovine endothelial cell plasminogen activator inhibitor. Purification and heat activation.牛内皮细胞纤溶酶原激活物抑制剂。纯化与热激活。
Eur J Biochem. 1988 Sep 1;176(1):81-7. doi: 10.1111/j.1432-1033.1988.tb14253.x.
3
Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.编码人β-迁移内皮细胞型纤溶酶原激活物抑制剂的cDNA的克隆与序列分析
Proc Natl Acad Sci U S A. 1986 Sep;83(18):6776-80. doi: 10.1073/pnas.83.18.6776.
4
Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha.培养的牛主动脉内皮细胞中1型纤溶酶原激活物抑制剂基因表达的调控。转化生长因子-β、脂多糖和肿瘤坏死因子-α的诱导作用。
J Biol Chem. 1989 Jun 25;264(18):10396-401.
Zotero 插件